02.03.2010 • NewsAmfloraBASFgenetically modified

EC Gives Amflora Starch Potato the Green Light

The European Commission has approved Amflora, BASF's genetically optimized starch potato, for commercial application in Europe. The potato can now be used for the production of industrial starch.

"After waiting for more than 13 years, we are delighted that the European Commission has approved Amflora," said Stefan Marcinowski, member of the board of executive directors of BASF.

The European Food Safety Authority (EFSA) confirmed on several occasions during the approval process that Amflora is safe for humans, animals and the environment, BASF said in a press statement.

Now that the European Commission has given its approval to Amflora's commercial cultivation, Sweden as the "rapporteur" country will formally issue its legal approval. The application for approval of Amflora was filed in Sweden in 1996.

Amflora produces pure amylopectin starch used in certain technical applications. Food use is not foreseen. It was developed in collaboration with experts from the European starch industry to respond to the demand for pure amylopectin starch. Conventional potatoes produce a mixture of amylopectin and amylose starch. For many technical applications, such as in the paper, textile and adhesives industries, pure amylopectin is advantageous, but separating the two starch component is uneconomical.

BASF said the industry will benefit from high-quality Amflora starch that optimizes industrial processes: it gives paper a higher gloss, and concrete and adhesives can be processed for a longer period of time. This reduces the consumption of energy, additives and raw materials such as water.

In addition, the European Commission also said it had approved three genetically modified corn varieties made by U.S. biotech firm Monsanto for food and feed uses and import and processing in the EU.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.